You are about to leave the Clinical Value website now.

Cancel

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis

Quick Summary

This study aimed to compare the performance of surveillance imaging with or without alpha fetoprotein (AFP) for early detection of hepatocellular carcinoma (HCC) in patients with cirrhosis. The researchers searched MEDLINE and SCOPUS and found that ultrasound alone had low sensitivity for detecting early-stage HCC, but the addition of AFP significantly increased sensitivity. The study concluded that ultrasound plus AFP measurement is a more effective surveillance strategy for detecting HCC in clinical practice. However, only a few studies evaluated computed tomography or magnetic resonance image-based surveillance, which detected HCC with high sensitivity.

Authors: Kristina Tzartzeva, Joseph Obi, Nicole E. Rich, Neehar D. Parikh, Jorge A. Marrero, Adam Yopp, Akbar Waljee, Amit G. Singal

You May Also Like

12 February 2026

LEAD Perspective: Evaluating GAAD – A Malaysian Multicentre Study

Read More
12 February 2026

LEAD Perspective: The Taiwan Liver Story – Hepatitis Elimination and HCC Surveillance

Read More
12 February 2026

LEAD Perspective: Asia Pacific Consensus Statement on the clinical and economic utility of biomarker-based algorithms in the early detection and surveillance of HCC

Read More

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.